Physician profile
Max Ryan Haffner
NPI 1700323425
$63,042.52
in general payments reported to CMS, 2019-2025
10 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,835 · 2020: $481 · 2021: $3,642 · 2022: $1,670 · 2023: $484 · 2024: $33K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $45K · Travel and Lodging: $4,062 · Food and Beverage: $3,854 · Consulting Fee: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $45,000.00 |
| Travel and Lodging | $4,061.53 |
| Food and Beverage | $3,853.60 |
| Consulting Fee | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $25,315.25 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Spatial Frame, Q-Fix |
| Arthrex, INC. | $21,333.13 | 2024-2025 | |
| Sequoia Surgical, INC. | $8,157.84 | 2019-2022 | |
| Stryker Corporation | $4,368.18 | 2022-2025 | Mako, T2, Aequalis Perform Reversed |
| Encore Medical, LP | $2,737.56 | 2025 | Djo Surgical |
| Evolution Surgical, INC | $429.83 | 2023-2025 | |
| Peerless Surgical INC. | $401.04 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $137.68 | 2025 | Tapestry |
| Depuy Synthes Sales INC. | $134.87 | 2024-2025 | Na, Milagro |
| Catalyst Orthoscience | $27.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Max Haffner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.